Tags: Medicare | Trump Administration | rebate | drugs | medicaid

Report: White House Kills Plan for Drug Rebate Rule

prescription drug prices shown
(Fotolia)

By    |   Thursday, 11 July 2019 09:02 AM

The Trump administration has backed away from a key part of its plan to lower drug prices, Axios is reporting.

The proposal would have changed the rebate program now in place for pharmacy benefit managers. The managers negotiate discounted prices in the form of a rebates, according to Axios. However, they are permitted to keep some of the rebates as profit.

Under the administration’s proposal, that arrangement would not have been permitted for Medicare and Medicaid and the managers would have had to pass the rebates to patients at the pharmacy counter.

But White House spokesman Judd Deere told Axios that part of the plan is now dead.

“Based on careful analysis and thorough consideration, the president has decided to withdraw the rebate rule," Deere said. “President (Donald) Trump will consider using any and all tools to ensure that prescription drug costs will continue to decline.”

Politico noted the rebate proposal had been a centerpiece of the administrations strategy to lower drug prices.

And Axios reported the decision to back away from it will now increase pressure on the administration to finalize a proposal that would set Medicare’s prices for certain drugs based on the prices other nations pay.

© 2019 Newsmax. All rights reserved.

   
1Like our page
2Share
Newsfront
The Trump administration has backed away from a key part of its plan to lower drug prices, Axios is reporting.
rebate, drugs, medicaid
199
2019-02-11
Thursday, 11 July 2019 09:02 AM
Newsmax Media, Inc.
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved